LABD ETF

LABD ETF
$5.98
See how much of LABD you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
+20.97%
3 Months
-36.36%
6 Months
-50.85%
YTD
-55.66%
1 Year
-85.58%
3 Years (annualized)
-57.92%
5 Years (annualized)
-46.55%
10 Years (annualized)
-56.68%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would LABD have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
S&P Biotechnology Select Industry Index(^SPSIBI:SP)
This ETF (YTD)
-55.66%
Peer Avg (YTD)
-0.65%
vs Peers
-55.01%

LABD ETF Performance

LABD performance across multiple time periods: 1-month 20.97%, YTD -55.66%, 1-year -85.58%, 3-year -57.92%, 5-year -46.55%, 10-year -56.68%.

LABD returns trail the peer average of -0.65% YTD. With an expense ratio of 1.07%, investors should weigh costs against performance when evaluating this ETF.

LABD vs another fund shows side-by-side returns. LABD alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+20.97%N/A
3 Months-36.36%N/A
6 Months-50.85%N/A
1 Year-85.58%N/A
3 Years-57.92%N/A
5 Years-46.55%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized